MZT(株)ゼブラフィッシュ創薬研究所

  • HOME
  • 研究開発
  • メンバー
  • アルバム
  • リンク
  • 研究員募集
  • アクセス
  • HOME
  • >
  • Publication List English
  • >
  • 詳細

最近の記事

2024/08/06
Validation of a new protocol for a zebrafish MEFL (malformation or embryo-fetal lethality) test method that conforms to the ICH S5 (R3) guideline.
2024/05/21
In vivo assessment of individual and total proteinuria in zebrafish larvae using the solvatochromic compound ZMB741
2021/10/31
Generation of a Transgenic Zebrafish Line for In Vivo Assessment of Hepatic Apoptosis
2021/08/19
Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Drug Discovery Screening and Personalized Medicine
2021/07/09
Establishment of a Quality Control Protocol for Zebrafish Developmental Toxicity Studies
2020/10/13
Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish
2020/05/28
A novel orexin antagonist from a natural plant was discovered using zebrafish behavioural analysis
2019/10/15
C3orf70 Is Involved in Neural and Neurobehavioral Development
2019/09/22
Generation of a Triple-Transgenic Zebrafish Line for Assessment of Developmental Neurotoxicity during Neuronal Differentiation
2019/07/17
Aging-associated microstructural deterioration of vertebra in zebrafish

一覧に戻る

2021/07/09
  • CiteULike
  • reddit
  • StumbleUpon
  • linkedin
  • Delicious
  • Mendeley
  • はてなブックマーク
  • Youtube
  • Google+
  • Twitter
  • Facebook

Establishment of a Quality Control Protocol for Zebrafish Developmental Toxicity Studies

Establishment of a Quality Control Protocol for Zebrafish Developmental Toxicity Studies
Toshio Tanaka 1, 2, Hajime Kojima 3, Michio Fujiwara 4, Kanako Mori 4, Kyoko Yamamoto 1, 2, Kayoko Yamada 1, 2, Yuka Mizutani 1, 2, Izumi Mori Aoi 1, 2, Yukiko Kato 1, 2

1Systems Pharmacology, Graduate School of Medicine, Mie University
2Medical Zebrafish Research Center, Mie University
3Safety Prediction and Evaluation Division, National Institute of Health Sciences
4Safety Research Institute, Astellas Pharma Inc.

On January 29, 2021, PMDA published the DETECTION OF REPRODUCTIVE AND DEVELOPMENTAL TOXICITY FOR HUMAN PHARMACEUTICAL S5(R3) by ICH. And zebrafish developmental toxicity test as an alternative method is now in full swing in Japan. In this study, we have established a zebrafish quality control protocol, which is the most important basis for this zebrafish developmental toxicity test. We found that it was possible to remove these low-quality fertilized eggs, thereby reducing false positive frequency and enhancing the accuracy of zebrafish developmental toxicity testing.

574
The most frequently used zebrafish AB line in the world was obtained from ZIRC, USA. We first analyzed 12,919 fertilized eggs and found that 290 eggs (2.3%) had died by 3 hours after fertilization. By 3 hours after fertilization, 290 (2.3%) of the fertilized eggs had died, and 2,055 (16.3%) had morphological abnormalities. By 24 hours after fertilization, 4,646 eggs (36%) were found to be dead. However, the survival rates from 1 to 6 days after fertilization were 64% (1 dpf), 61.3% (2 dpf), and 59.0% (6 dpf), which were stable compared to the rapid decline in survival rate at 24 hours after fertilization. On the other hand, the results of time-lapse imaging at 3 hours to 6 days after fertilization revealed that abnormal egg imaging at 3 hours after fertilization can predict sudden death at least up to 24 hours after fertilization, and diagnostic criteria to enhance the ability to predict death up to 24 hours after fertilization were established. We established diagnostic criteria to enhance the ability to predict mortality up to 24 hours after fertilization. As a result, we report that it was possible to remove these low-quality fertilized eggs prior to the start of compound exposure (6 hpf) for developmental toxicity testing, thereby reducing false positive frequency and enhancing the accuracy of zebrafish developmental toxicity testing.

関連リンク

  • 三重大学大学院医学系研究科システムズ薬理学
  • The 48th Annual Meeting of the Japanese Society of Toxicology